Skip to content

Clinical trials

Cardiomyopathies trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Czechia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20142
20181
20194
20202
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals4
Abbott Medical Devices3
Ancora Heart, Inc.2
EBR Systems, Inc.1
Eidos Therapeutics, a BridgeBio company1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Lexeo Therapeutics1
St. Anne's University Hospital Brno, Czech Republic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies15
Amyloidosis7
Heart Failure6
Heart Diseases5
Cardiovascular Diseases3
Ventricular Dysfunction3
Amyloidosis, Familial2
Alzheimer Disease1
Amyloid Neuropathies, Familial1
Bradycardia1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.